Abraham N. Oler

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Henderson, NV
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Mark Guerin as attorney-in-fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Abraham N. Oler

Form 4 holding SVP Corp Dev & Gen Counsel

Onconova Therapeutics, Inc.

Security class
Common Stock
Shares / value
24,514
Estimated value
$25,004
Report date
28 Jan 2022
Price
$1.02
Ownership
Direct
Form 4 holding SVP Corp Dev & Gen Counsel

Onconova Therapeutics, Inc.

Security class
Restricted Stock Units
Shares / value
17,633
Estimated value
$11,814
Report date
07 Feb 2022
Price
$0.6700
Ownership
Direct
Underlying class
Common stock
Underlying amount
Form 4 holding SVP Corp Dev & Gen Counsel

Onconova Therapeutics, Inc.

Security class
Stock Option (right to purchase)
Shares / value
54,050
Estimated value
Report date
07 Feb 2022
Price
Ownership
Direct
Underlying class
Common stock
Underlying amount

Insider Reports Filed by Abraham N. Oler

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .